Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESETT: Fosphenytoin, Valproic Acid, or Levetiracetam for Status Epilepticus
NCT01960075Phase 3Completed
- Sponsor
- University of Virginia
- Start
- Oct 2015
- Primary completion
- Feb 2019
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fosphenytoin, levetiracetam and valproic acid in status epilepticus (SE), sponsored by University of Virginia. Started Oct 2015; status: completed.
02
Drugs
fosphenytoinlevetiracetamvalproic acid
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT01960075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01960075.